QR Code

Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study

Abstract This single-centre retrospective cohort study reports on the results of a descriptive (non-comparative) retrospective cohort study of early initiation of antivirals and combined monoclonal antibody therapy (mAbs) in 48 severely immunocompromised patients with COVID-19. The study assessed th...

Description complète

Enregistré dans:
Auteurs principaux: Salvatore Rotundo, Lavinia Berardelli, Sara Gullì, Valentina La Gamba, Rosaria Lionello, Alessandro Russo, Enrico Maria Trecarichi, Carlo Torti
Format: Artigo
Langue:Inglês
Publié: BMC 2024-06-01
Collection:BMC Infectious Diseases
Sujets:
SARS-CoV-2
COVID-19
Immunocompromised
Combined therapy
Antivirals
Monoclonal antibodies
Accès en ligne:https://doi.org/10.1186/s12879-024-09466-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires